We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Combined Ultrasound Technologies Provide “One Stop Shop” Evaluation of Cardiovascular Disease Risk

By MedImaging International staff writers
Posted on 25 Nov 2013
Print article
A novel suite of ultrasound imaging modalities for both cardiac and vascular studies provides clinicians with a wide range of tools for assessing a patient’s risk of cardiovascular (CV) disease rapidly and effectively, often before symptoms occur. The technology was developed to provide a “step change” in terms of early detection and prevention of cardiovascular disease using ultrasound.

At this year’s EuroEcho-Imaging Conference, held December 11–14, 2013, in Istanbul (Turkey), global medical imaging manufacturer, Esaote (Genoa, Italy), will present the Prevention Suite, which includes four sophisticated ultrasound imaging technologies: CFI (coronary flow imaging), XStrain, RFQIMT (radiofrequency quality intima media thickness), and RFQAS (radiofrequency-based quality arterial stiffness), which measure coronary flow quantification, cardiac deformation indexes, carotid intima-media thickness and arterial stiffness, respectively. The vascular measurements are performed using RF signal analysis, which provides high spatial resolution for greater accuracy.

Prof. Fausto Rigo, head of cardiac diagnostic imaging department at Dell’Angelo Hospital (Mestre-Venice, Italy), has used Esaote’s Prevention Suite extensively in both inpatient and outpatient examinations. “For clinicians ranging from GPs [general practitioners] to cardiologists, Prevention Suite is a unique and technically superb ‘one-stop-shop’ for cardiovascular assessment. It allows us to quickly and reliably make an appraisal of the patient, providing information about the actual biological risk of atherosclerosis. Prevention Suite’s resolution for vessel analysis is particularly impressive. There is no equivalent that allows us this multiplicity of information in the preclinical phase. Patients are fascinated by the examination too, and Prevention Suites’ real-life images are highly persuasive in convincing them to modify their lifestyle.”

An early detection strategy using ultrasound imaging of major cardiovascular areas is an important way of addressing an extremely costly issue: In 2011, the American Heart Association estimated that by 2030 the cost of treating cardiovascular diseases would upsurge from USD 273 to USD 818 billion.

Prof. Cristina Giannattasio, head of cardiology IV, cardiologic department at Niguarda Hospital (Milan, Italy), noted, “Atherosclerosis is one of the pathologies which can remain asymptomatic for a long time. The availability of dedicated cardiac and vascular measurements in the same device offers a more user-friendly and comprehensive assessment with the benefit of being able to detect early risk of CV disease. In the future, preventative approaches will be the best way of reducing morbidity and mortality.”

Ongoing clinical studies involving hundreds of patients at clinical centers throughout Europe have started to show the benefits of a preventative screening approach. Prof. Rigo explained, “The integration of cardiac and vascular assessments will help physicians identify the actual biological risk of atherosclerosis. Once clinical risk is identified, clinicians can work with patients on early intervention strategies and lifestyle modification before the risk of CVD escalates. As well as having clear patient benefits, preclinical assessments may help prevent hospitalizations and acute therapies, yielding significant long-term cost savings.”

Prevention Suite is available across Esaote’s range of ultrasound systems. XStrain 4D or RFQAS are not currently available in the United States.

Related Links:

Esaote


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Brachytherapy Planning System
Oncentra Brachy
New
X-Ray Detector
FDR-D-EVO III
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.